Vimarsana
Biggest News Aggregation in the World

Arvinas Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arvinas Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arvinas Chart Today - Breaking & Trending Today

Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC Protein Degrader for Neurodegenerative Disease - Vimarsana News

Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC Protein Degrader for Neurodegenerative Disease

Published: February 20, 2024

20.02.2024 - – ARV-102 is a novel oral PROTAC protein degrader designed to cross the blood-brain barrier and target leucine-rich repeat kinase 2 (LRRK2) – – The Phase 1 trial of ARV-102 will evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics ... Seite 1

Source: wallstreet-online.de
Related Topics:
Angelam CacaceArvinas IncCentre For Human Drug ResearchHuman Drug ResearchSenior Vice PresidentArvinas ChartRvinas KursRvinas Aktie
Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023 - Vimarsana News

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023

Published: October 15, 2023

16.10.2023 - NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) - Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will present updated Phase 1/2 data for vepdegestrant (ARV-471) at the 2023 European Society for Medical ... Seite 1

Source: wallstreet-online.de
Related Topics:
Arvinas IncPfizer IncEuropean Society For Medical OncologyPfizer Announce Upcoming VepdegestrantPoster PresentationMedical OncologyArvinas ChartRvinas KursRvinas Aktie